Parallel Session IV: Europe-China Biopharmaceutical Cross-border Cooperation Matchmaking and Exchange Meeting
| Hosted by | China Chamber of International Commerce, European Union Chamber of Commerce in China | ||
| Supported by: | China-Europe Association for Technical and Economic Cooperation, Drug Information Association (DIA), Qiantuhui Medical Technology Co., Ltd., Biomedical Informatics Society of Chengdu | ||
| Moderator | Zhou Guangyao | Deputy Director-General of Department of Exhibitions & Events, China Chamber of International Commerce (CCOIC) | |
| 14:00-14:20 | Part I: Opening Remarks | ||
| Remarks by a Chinese leader: Current Status and Vision of China-Europe Biopharmaceutical Industry Cooperation | |||
| Keynote Speaker | Chen Jingyue | Executive Vice President and Secretary General of China-Europe Association for Technical and Economic Cooperation | |
| Remarks by an Europe leader: Opportunities in Europe-China Biopharmaceutical Industry Cooperation | |||
| Keynote Speaker | Yang Ying | Board Member of the Southwest China Chapter of the European Union Chamber of Commerce in China | |
| 14:20-14:50 | Part II: Industrial Parks Investment Promotion | ||
| Chengdu Tianfu International Bio-town Investment Promotion | |||
| Chengdu Medical City Investment Promotion | |||
| 14:50-15:40 | Part III: Keynote Speeches | ||
| Strategies, Challenges, and Breakthroughs in Chinese Enterprises Expanding to Europe | |||
| Speaker: | Dr. Hou Yan | Chair of the Regulatory Science Translation and Evaluation Special Committee of China Food and Drug Institutions Quality and Safety Promotion Association, Secretary General of APEC International Clinical Multicenter Joint Laboratory, and Director of National Institute of Drug and Device Regulation, Peking University | |
| Scientific Dialogue with the European Medicines Agency (EMA) to Support New Drug Marketing in Europe | |||
| Speaker: | Yan Xiaojun | Strategic Advisor to DIA Global Board of Directors and Former Senior Vice President of BeiGene | |
| AstraZeneca's Localization Strategy and Practice | |||
| Speaker: | He Ling | Managing Director, AstraZeneca-CICC Healthcare Investment Fund | |
| Innovation in Women's Health: Co-Building an Ecosystem to Empower the “Her Era” | |||
| Speaker: | Lyu Hao | Senior Manager of Innovation & External Cooperation, Women's Health, Bayer | |
| Expanding Molecular Diversity to Enable Innovative Drug R&D - Opportunities, Challenges, and Ecosystem Co-Building for China-Europe Biopharmaceutical Cooperation | |||
| Speaker: | Dr. Dou Dengfeng | Vice President of Strategy, HitGen Inc. | |
| 15:40-16:10 | Part IV: Roundtable Dialogue (I): AI's Empowerment of Biopharmaceuticals | ||
| Moderator: | Xiong Tao | Vice President of BGI Global Development | |
| Panelists: | Dr. Chen Bin | Executive Director and Secretary General of the Digital-Intelligent Proactive Health Industry Collaborative Innovation Center of China Inspection and Testing Society, Head of Medical Department of the Engineering Research Center of Human-Robot Hybrid Intelligent Technologies and Systems, Ministry of Education, and Executive President and Secretary General of Biomedical Informatics Society of Chengdu: | |
| Judy Lux | Co-founder and COO of Clincase, a German medical clinical data management company | ||
| Liu Jia | Vice Chair of Professional Committee on Talent Development and International Exchange, Drug Information Association (DIA), and Former Vice President and Member of Clinical Research Management Course Development Committee, Tigermed | ||
| Praveen Bezawada | Managing Director and CTO, Freyr (Chengdu) Technology Co., Ltd. | ||
| Dr. Alex Wang | Chairman of Pharmaceutical Engineering Professional Committee of Guangdong Pharmaceutical Association, Vice Chairman of Business Development Special Committee of China Biopharmaceutical Industry Chain Innovation and Transformation Alliance, and Chairman of Guangzhou PJ Partner Co., Ltd. | ||
| 16:10-16:40 | Roundtable Dialogue (II): Europe-China Biopharmaceutical Cross-border Cooperation and Capital Empowerment | ||
| Moderator: | Liu Jin | Vice Chairwoman of Chinese Financial Association of Hong Kong and Vice Chairwoman of WestVac Biopharma | |
| Panelists: | Gong Yuan | Deputy General Manager of Sichuan Development Holding Co., Ltd. | |
| Chen Minzhi | Head of Product Strategy and Planning, GlaxoSmithKline (China) Investment Co., Ltd. | ||
| Gao Bo | Head of Enterprise Division, Bio-industry Development Bureau, Chengdu High-tech Industrial Development Zone | ||
| Liu Min | BD Director of Haisco Pharmaceutical Group | ||
| Chen Yan | Senior Business Development Manager of Pierre Fabre (Shanghai) Medical Technology Co., Ltd. | ||
| 16:40:00 | End of the meeting | ||
Cooperation partner: Pierre Fabre Laboratories